Clinical Trial Update: Clinical Study of Cannabidiol in Children, Adolescents, and Young Adults With Fragile X Syndrome [Phase 3]

View source ↗

Summary

This update covers a Phase 3 clinical trial evaluating cannabidiol for Fragile X Syndrome in children, adolescents, and young adults, with the study status list…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fragile Syndrome

Drugs mentioned

• ZYN002 (cannabidiol) (cannabidiol)

Snippet

Sponsor: Zynerba Pharmaceuticals, Inc. | Conditions: Fragile X Syndrome | Phase 3 | Status: COMPLETED